HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reactivation of Lysosomal Ca2+ Efflux Rescues Abnormal Lysosomal Storage in FIG4-Deficient Cells.

Abstract
Loss of function of FIG4 leads to Charcot-Marie-Tooth disease Type 4J, Yunis-Varon syndrome, or an epilepsy syndrome. FIG4 is a phosphatase with its catalytic specificity toward 5'-phosphate of phosphatidylinositol-3,5-diphosphate (PI3,5P2). However, the loss of FIG4 decreases PI3,5P2 levels likely due to FIG4's dominant effect in scaffolding a PI3,5P2 synthetic protein complex. At the cellular level, all these diseases share similar pathology with abnormal lysosomal storage and neuronal degeneration. Mice with no FIG4 expression (Fig4(-/-)) recapitulate the pathology in humans with FIG4 deficiency. Using a flow cytometry technique that rapidly quantifies lysosome sizes, we detected an impaired lysosomal fission, but normal fusion, in Fig4(-/-) cells. The fission defect was associated with a robust increase of intralysosomal Ca(2+) in Fig4(-/-) cells, including FIG4-deficient neurons. This finding was consistent with a suppressed Ca(2+) efflux of lysosomes because the endogenous ligand of lysosomal Ca(2+) channel TRPML1 is PI3,5P2 that is deficient in Fig4(-/-) cells. We reactivated the TRPML1 channels by application of TRPML1 synthetic ligand, ML-SA1. This treatment reduced the intralysosomal Ca(2+) level and rescued abnormal lysosomal storage in Fig4(-/-) culture cells and ex vivo DRGs. Furthermore, we found that the suppressed Ca(2+) efflux in Fig4(-/-) culture cells and Fig4(-/-) mouse brains profoundly downregulated the expression/activity of dynamin-1, a GTPase known to scissor organelle membranes during fission. This downregulation made dynamin-1 unavailable for lysosomal fission. Together, our study revealed a novel mechanism explaining abnormal lysosomal storage in FIG4 deficiency. Synthetic ligands of the TRPML1 may become a potential therapy against diseases with FIG4 deficiency.
AuthorsJianlong Zou, Bo Hu, Sezgi Arpag, Qing Yan, Audra Hamilton, Yuan-Shan Zeng, Carlos G Vanoye, Jun Li
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci) Vol. 35 Issue 17 Pg. 6801-12 (Apr 29 2015) ISSN: 1529-2401 [Electronic] United States
PMID25926456 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2015 the authors 0270-6474/15/356801-12$15.00/0.
Chemical References
  • Flavoproteins
  • Heterocyclic Compounds, 4 or More Rings
  • Lysosomal-Associated Membrane Protein 1
  • vacuolin-1
  • Fig4 protein, mouse
  • Phosphoinositide Phosphatases
  • GTP Phosphohydrolases
  • Calcium
Topics
  • Animals
  • Animals, Newborn
  • Calcium (metabolism)
  • Cells, Cultured
  • Down-Regulation (drug effects, genetics)
  • Fibroblasts (drug effects, ultrastructure)
  • Flavoproteins (genetics, metabolism)
  • GTP Phosphohydrolases (metabolism)
  • Ganglia, Spinal (cytology)
  • Heterocyclic Compounds, 4 or More Rings (pharmacology)
  • Humans
  • In Vitro Techniques
  • Lysosomal-Associated Membrane Protein 1 (genetics, metabolism)
  • Lysosomes (drug effects, metabolism, pathology)
  • Membrane Potentials (drug effects, genetics, physiology)
  • Mice
  • Mice, Transgenic
  • Motor Neurons (drug effects, metabolism, ultrastructure)
  • Neurons (drug effects, metabolism, ultrastructure)
  • Phosphoinositide Phosphatases
  • Schwann Cells (metabolism, ultrastructure)
  • Sciatic Nerve (cytology)
  • Spinal Cord (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: